Russell Investments Group’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-56,621
Closed -$424K 3015
2022
Q2
$424K Sell
56,621
-10,193
-15% -$71.8K ﹤0.01% 2327
2022
Q1
$607K Sell
66,814
-17,923
-21% -$138K ﹤0.01% 2163
2021
Q4
$593K Sell
84,737
-4,661
-5% -$48.8K ﹤0.01% 2379
2021
Q3
$1.02M Sell
89,398
-301
-0.3% -$4.4K ﹤0.01% 2179
2021
Q2
$1.44M Buy
89,699
+38,527
+75% +$661K ﹤0.01% 2131
2021
Q1
$914K Sell
51,172
-52,290
-51% -$903K ﹤0.01% 2287
2020
Q4
$1.4M Buy
103,462
+55,387
+115% +$669K ﹤0.01% 1946
2020
Q3
$564K Buy
+48,075
New +$586K ﹤0.01% 2338
2019
Q1
Sell
-375,935
Closed -$13.5M 3053
2018
Q4
$13.5M Sell
375,935
-34,953
-9% -$1.64M 0.03% 670
2018
Q3
$25.3M Buy
410,888
+113,598
+38% +$7.3M 0.05% 466
2018
Q2
$20.1M Buy
297,290
+5,434
+2% +$304K 0.04% 533
2018
Q1
$15.8M Sell
291,856
-44,346
-13% -$2.48M 0.03% 731
2017
Q4
$20.8M Sell
336,202
-52,464
-13% -$3.18M 0.03% 621
2017
Q3
$18.9M Buy
388,666
+156,056
+67% +$8.51M 0.03% 662
2017
Q2
$12.2M Buy
232,610
+207,146
+813% +$9.64M 0.02% 814
2017
Q1
$1.16M Sell
25,464
-22,533
-47% -$1M ﹤0.01% 2023
2016
Q4
$1.81M Buy
+47,997
New +$1.82M ﹤0.01% 1858

Other funds holding AERI

Russell Investments Group's AERI Position: Q3 2022 in Review

Russell Investments Group sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 56,621 shares — an estimated $424K sold.

Russell Investments Group first reported a position in AERI in Q4 2016 and held it in 17 quarters. The position peaked at $25.3M in Q3 2018. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

  • Russell Investments Group reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Russell Investments Group sold 56,621 Aerie Pharmaceuticals shares in Q3 2022, an estimated $424K.
  • Russell Investments Group first reported a position in Aerie Pharmaceuticals in Q4 2016 and held it in 17 quarters.
  • Russell Investments Group's Aerie Pharmaceuticals position peaked at $25.3M in Q3 2018.
  • 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Russell Investments Group's 13F filing for Q3 2022, filed 4 Nov 2022.